TRB’s National Cooperative Highway Research Program (NCHRP) Report 702: Precision of the Dynamic Modulus and Flow Number Tests Conducted with the Asphalt Mixture Performance Tester describes the development of precision statements for the dynamic modulus and flow number tests conducted with the Asphalt Mixture Performance Tester.
The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic. The rapid development of COVID-19 vaccines has demonstrated what is possible with extensive data sharing, researchers who have the necessary resources and novel technologies to conduct and apply their research, rolling review by regulators, and public-private partnerships. As demonstrated throughout the response to COVID-19, the process of research and development of novel vaccines can be significantly optimized when stakeholders are provided with the resources and technologies needed to support their response. Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee's findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science.
TRB's National Cooperative Highway Research Program (NCHRP) Report 709: Investigation of Short-Term Laboratory Aging of Neat and Modified Asphalt Binders provides a proposed method of testing for short-term laboratory aging of neat and modified asphalt binders using the modified German rotating flask as an alternative to the rolling thin film oven test. The following appendixes A-E to NCHRP Report 709 are only available in electronic format."--
Explores whether combining the environmental conditioning system with the simple performance test would provide a superior procedure for determining the moisture susceptibility of hot-mix asphalt (HMA).
TRB's National Cooperative Highway Research Program (NCHRP) Report 691: Mix Design Practices for Warm-Mix Asphalt explores a mix design method tailored to the unique material properties of warm mix asphalt technologies. Warm mix asphalt (WMA) refers to asphalt concrete mixtures that are produced at temperatures approximately 50°F (28°C) or more cooler than typically used in the production of hot mix asphalt (HMA). The goal of WMA is to produce mixtures with similar strength, durability, and performance characteristics as HMA using substantially reduced production temperatures. There are important environmental and health benefits associated with reduced production temperatures including lower greenhouse gas emissions, lower fuel consumption, and reduced exposure of workers to asphalt fumes. Lower production temperatures can also potentially improve pavement performance by reducing binder aging, providing added time for mixture compaction, and allowing improved compaction during cold weather paving. Appendices to NCHRP Report 691 include the following. Appendices A, B, and D are included in the printed and PDF version of the report. Appendices C and E are available only online.
TRB's National Cooperative Highway Research Program (NCHRP) Report 567: Volumetric Requirements for Superpave Mix Design examines whether changes to the recommended Superpave mix design criteria for voids in mineral aggregate, voids filled with asphalt, and air voids content might further enhance the performance and durability of hot-mix asphalt.
TRB¿s National Cooperative Highway Research Program (NCHRP) Report 614: Refining the Simple Performance Tester for Use in Routine Practice explores the develop of a practical, economical simple performance tester (SPT) for use in routine hot-mix asphalt (HMA) mix design and in the characterization of HMA materials for pavement structural design with the Mechanistic-Empirical Pavement Design Guide.
Introduction and Research Approach -- Findings -- Interpretation, Appraisal, and Applications -- Conclusions and Recommendations -- References -- Appendixes.
Explores whether combining the environmental conditioning system with the simple performance test would provide a superior procedure for determining the moisture susceptibility of hot-mix asphalt (HMA).
TRB's National Cooperative Highway Research Program (NCHRP) Report 709: Investigation of Short-Term Laboratory Aging of Neat and Modified Asphalt Binders provides a proposed method of testing for short-term laboratory aging of neat and modified asphalt binders using the modified German rotating flask as an alternative to the rolling thin film oven test. The following appendixes A-E to NCHRP Report 709 are only available in electronic format."--
The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic. The rapid development of COVID-19 vaccines has demonstrated what is possible with extensive data sharing, researchers who have the necessary resources and novel technologies to conduct and apply their research, rolling review by regulators, and public-private partnerships. As demonstrated throughout the response to COVID-19, the process of research and development of novel vaccines can be significantly optimized when stakeholders are provided with the resources and technologies needed to support their response. Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee's findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.